An Introduction to Movement Disorders
Movement disorders encompass a range of conditions including ataxia, dystonia, essential tremor, multiple system atrophy, Parkinson’s disease (PD) and restless legs syndrome. The treatment landscape of PD has seen numerous developments, including the introduction of dopamine agonists and MAO-B inhibitors, along with device-assisted therapies that prove particularly useful in advanced-stage disease. The first-line treatment of ataxia with botulinum toxin is long established, but new preparations of the drug are likely to contribute to the future landscape.
Browse video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and peer-reviewed articles from the journal portfolio. This is complimented by a range of educational activities from our expert faculty, with patient outcomes at the forefront.
Our supporting partners do not constitute an endorsement of the content on this page.
Movement Disorders Content
World Congress on Controversies in Neurology (CONy): Presidential highlights, Amos D. Korczyn
The 17th World Congress on Controversies in Neurology (CONy) took place March 23-25 2023 in Dubrovnik, Croatia. Prof. Amos D. Korczyn, CONy President (University of Tel-Aviv, Tel-Aviv, Israel) joined touchNEUROLOGY to discuss the main aims and focus of the recent CONy meeting, the unique debate presentation style, and the most exciting debates, topics and highlights […]
The place of on-demand therapy in the treatment of OFF episodes
Learn about the treatment paradigm for OFF and the place of on-demand therapy in it.
Multidisciplinary insights on the symptoms, diagnosis and modern medical management of Duchenne muscular dystrophy
A multidisciplinary team and a patient advocate discuss the symptoms, diagnosis and modern medical management of Duchenne muscular dystrophy
- Recognize the signs and symptoms of Duchenne muscular dystrophy
- Discuss the diagnosis of Duchenne muscular dystrophy and the challenges associated with pre-symptomatic screening for the condition
- Describe the medical management of Duchenne muscular dystrophy and the importance of the multidisciplinary team
Improving the alpha-mannosidosis patient journey
An expert gives her perspectives on the history and prevalence of alpha-mannosidosis, its diagnosis and treatment options
- Describe the prevalence and natural history of the rare lysosomal storage disorder alpha-mannosidosis (AM)
- Explain how diagnosis of AM may be approached, and describe the methods of disease identification
- Outline current and emerging management and treatment options for patients with AM
The impact of delayed ON: Treating OFF episodes in patients with Parkinson’s disease
Leading experts Stuart Isaacson MD, Yasar Torres-Yaghi MD, Rajesh Pahwa MD discuss how to reduce the impact of delayed ON in Parkinson’s disease
A Bird in the Hand: A Neurologist’s Guide to Efficient Tweeting in the Age of Social Media
touchREVIEWS in Neurology 2022;18(2):76–80 DOI: https://doi.org/10.17925/USN.2022.18.2.76
The surge in social media use seems to have become a sign of our times. Social media has ramified into not only our personal lives but, importantly, also our professional lives and will continue to do so in the future.1–4 At the same time, more neurologists resorted to online learning modalities, including podcasts and social media […]
Highlights of the 15th World Congress of the International Neuromodulation Society: an expert interview with Prof. Marc Russo
Prof. Marc A. Russo President, International Neuromodulation Society Director of Hunter Pain Specialists, Hamilton Day Surgery Centre, Genesis Research Services, Broadmeadow, Australia Co-Director, Innervate Pain Management Program, Newcastle, Australia The 15th World Congress of the International Neuromodulation Society (INS) was held on May 21st-26th in Barcelona, Spain. This year’s congress had the theme: “Neuromodulation: […]
Assessment and Treatment of Myoclonus: A Review
touchREVIEWS in Neurology 2022;18(1):38–41 DOI: https://doi.org/10.17925/USN.2022.18.1.38
Myoclonus is defined as a sudden, brief, lightning-like muscle contraction.1 It was first described by Friedreich in 1881 when he detailed sharp jerks involving the bulk of a full muscle without marked limb or joint movement and called it paramyoclonus multiplex.2 Myoclonus may be described as either positive myoclonus (increase in contraction activity) or negative myoclonus (inhibition […]
Emerging Therapies in Friedreich’s Ataxia: A Review
touchREVIEWS in Neurology. 2022;18(1):32–7 DOI: https://doi.org/10.17925/USN.2022.18.1.32
It has been nearly 160 years since Friedreich’s ataxia (FRDA) was clinically recognized and described1 and 25 years since the FXN gene was discovered.2 Despite this, there are still no approved therapies for FRDA. FRDA is an autosomal, recessively inherited, neurodegenerative disease that typically presents in childhood and results in progressive gait and limb ataxia, with the extraneural features […]